The loss of normal weight-bearing activity, which occurs during bed rest, limb immobilization, and spaceflight, stimulates a catabolic response within the musculoskeletal system, which results in a loss of skeletal muscle mass and bone mineral. The mechanism by which loading of muscle and bone is sensed and translated into signals controlling tissue formation remains a major question in the field of musculoskeletal research. In this investigation, we have examined the ability of two potentially anti-atrophic proteins, IGF-I and Shh, to inhibit disuse atrophy within muscle and bone, when electroporated into skeletal muscle. We have found that electroporation and ectopic expression of IGF-I and/or Shh within the gastrocnemius/soleus muscle significantly stimulated muscle fiber hypertrophy and increases in muscle size. In addition, we report that electroporation and ectopic expression of IGF-I and/or Shh within the gastrocnemius/soleus muscle attenuated the lost of muscle fiber area, muscle mass, and muscle mass density that normally occurs during disuse muscle atrophy. Finally, we found that ectopic expression of IGF-I and Shh within the gastrocnemius/soleus muscle inhibits parameters of osteopenia within the tibia and fibula associated with hindlimb unloading. These results support the theory that skeletal muscle can regulate bone maintenance and could offer potentially novel and efficient therapeutic options for attenuating muscle and bone atrophy during aging, illness and spaceflight.
muscle specific proteins (5) . Unloading and disuse also lead to decreased bone formation and bone mass (6) . For example, during spaceflight astronauts can lose bone mineral density (BMD) at rates of 1.6% per month (7) . In addition, immobilization of the shoulder joint after surgery significantly reduces bone density of the humerus (8) . It appears that this type of bone loss is a result of reduced osteoblast function, depressed bone formation, and enhanced bone resorption (9, 10) .
The mechanism by which loading of muscle and bone is sensed and translated into signals controlling tissue formation remains a major question in the field of musculoskeletal research. Currently, no universally effective treatments are available for musculoskeletal atrophy because of the dearth of information to advance the knowledge of muscle and bone relationships. Several strategies have been used in an attempt to attenuate or reverse muscle atrophy and bone osteopenia associated with disuse. The success of these attempts appears to depends on the action of growth factors used, the delivery system employed, and the model of atrophy studied. For example, intramuscular injection of IGF-I inhibited muscle atrophy associated with denervation (11) , whereas administration of GH and/or IGF-I did not attenuate muscle atrophy associated with hindlimb suspension (12) . Exercise was required in addition to administration of GH and IGF-I to inhibit muscle degeneration associated with disuse atrophy (12) . However, in certain clinical situations such as bed-ridden or casted patients, exercise is not an option when attempting to attenuate muscle atrophy. In bone, infusion of IGF-II and IGFBP-2 inhibited the osteopenia associated with neurectomy (13) . Low-level mechanical signals were also found to be osteogenic and suppressed bone loss associated with hindlimb suspension (14) .
Although the aforementioned reports indicate varying degrees of success in attenuating either bone or muscle atrophy associated with disuse, to our knowledge no studies have analyzed the relationship and interactions between muscle and bone during loading and unloading in vivo. Muscle-derived cells have been used as a source of inducible osteoprogenitor cells for bone healing (15) . However, the concept of muscle regulating bone homeostasis, or vice versa, during unloading has not been rigorously investigated. The recent advances in DNA electroporation into skeletal muscle in vivo allow for sustained, high-level expression of cDNA constructs within muscle myofibers. This technique offers an efficient, alternative method for production of therapeutic proteins from skeletal muscle. In this investigation, we have examined the ability of two potentially anti-atrophic proteins, IGF-I and Shh, to inhibit disuse atrophy within muscle and bone, when electroporated into skeletal muscle. We have found that electroporation and ectopic expression of IGF-I and/or Shh induced significant muscle fiber hypertrophy. In addition, we report that IGF-I and/or Shh attenuated the loss of muscle fiber area, muscle mass, and muscle mass density that normally occurs during disuse muscle atrophy. Finally, we found that ectopic expression of IGF-I and Shh in skeletal muscle inhibits parameters of osteopenia associated with hindlimb unloading. These results support the theory that skeletal muscle can regulate bone maintenance and could offer potentially novel and efficient therapeutic options for attenuating muscle and bone atrophy during aging, illness, and spaceflight.
MATERIALS AND METHODS

Animals
Fifteen-week-old male NIH Swiss mice were purchased from Harlan labs (Indianapolis, IN). Animal care (feed and water ad libitum, light dark cycle) procedures followed reviewed and accepted PACUC protocols.
cDNA constructs
The porcine IGF-I cDNA in a pcDNA3.1 expression construct was previously described (16) . The rat full-length isoform of Shh in a pMT 21 expression construct was generously supplied by Dr. Anne-Gaelle Borycki (Centre for Developmental Genetics, Department of Biomedical Science, University of Sheffield). The cytomegalovirus (CMV)-LacZ was supplied by Center Commercial de Gros (17) . All plasmids were prepared using the endotoxin-free Qiagen MaxiPrep kits (Qiagen, Valencia, CA).
DNA injection and electroporation
Mice were anesthetized with an intraperitoneal injection of 0.01 ml/gram of a mixture of ketamine (100 mg/ml) and xylazine (20 mg/ml). In each experiment, there were three treatment groups. For all three groups of mice, one gastrocnemius/soleus muscle was injected with 50 µg of CMV LacZ. In one group of mice, 50 µl of a mixture of 20 µg of CMV-LacZ and 30 µg of the IGF-I expression construct was injected into the contralateral gastrocnemius/soleus muscle. In another group, 50 µl of a mixture of 20 µg of a CMV-LacZ and 30 µg of the Shh expression construct was injected into the contralateral gastrocnemius/soleus muscle. In the third group of mice, 50 µl of a mixture of 10 µg of CMV-LacZ, 20 µg of a Shh, and 20 µg of an IGF-I expression construct were injected into the contralateral gastrocnemius/soleus muscle. Five minutes after DNA injection, muscles were electroporated as previously described (18) .
Dual-energy X-ray absorptiometery
Dual-energy X-ray absorptiometry (DEXA) was used to measure of BMD, bone mineral content (BMC), and lean mass (muscle mass density; ref 19) . DEXA scans were performed using pDEXA Sabre (Norland Medical Systems Inc., Fort Atkinson, WI). Seven days post-DNA injection and electroporation; mice were anesthetized with an intraperitoneal injection of ketamine/xylazine as described. Mice were positioned in ventro-dorsal recumbency. The regions of interest were defined as a trapezoid area, which included the hindlimbs, pelvic bones, and the last three lumbar bones (Figure 1 ). Scans were started from the caudal part of the body and progressed cranially until the lumbar vertebra was visible on display screen. The scans were terminated at this point, and the final measurement scans were acquired.
Analysis of hypertrophy
Seven, fourteen, and thirty days post-DNA injection and electroporation, six mice from each treatment group were killed, and gastrocnemius/soleus muscles were removed, embedded in Tissue Tek (Fisher Scientific, Itasca, IL), and frozen with isopentane supercooled by liquid nitrogen. Muscles were then stored at -70°C until further analyzed. Muscles were crysectioned with a Shandon-Lipshaw cryostat at a thickness of 14 µm. Sections were allowed to dry at least for 4 h and then stored at -20 °C until further analysis.
To stain for ß-galactosidase activity, muscle sections were fixed for 10 min in 0.5% gluteraldhyde in PBS (pH 7.3), rinsed twice with PBS, and incubated in 1 mg per ml 5-bromo-4-chloro-3-indolyl-ß-galacto pyranoside, 5 mM potassium ferricyanide, 5 mM potassium ferrocynide, and 2 mM MgCl 2 in PBS at 37 °C fro 16 h (17). After being stained, sections were coverslipped with permount (Fisher, Itasca, IL). Images from stained sections were captured using a Leaf Micro-Lumina scanning digital camera (Scitex, Tel-Aviv, Israel). After image importation into Optimas Image Analysis Software (Media Cybernetics, Carlsbad, CA), the muscle fiber area was determined. Six to eight sections from each muscle were analyzed for each mouse. An average of 50 muscle fibers from each section was examined.
RNA isolation and analysis
Muscles were injected and electroporated, and 7 days after electroporation, the right and left gastrocnemius/soleus muscles were harvested. Total RNA was extracted from skeletal muscle using TriZol reagent according to the protocol described by the manufacturer (Life Technologies, Bethesda, MD). The concentration and purity of the RNA were determined by measurement of the optical densities at 260 and 280 nm and analyzed by gel electrophoresis. The RNA solutions were diluted to a working concentration of 1 µg/µl in DEPC treated water (0.1% DEPC to water, Invitrogen, Carlsbad, CA).
cDNA was prepared from RNA samples as described previously (20) . Briefly, a 20 µl reaction mix was made of 1x 1 st standard buffer (Life Technologies, Rockville, MD), 10 mM DTT, 1 mM dNTPs, and 5 µM random hexamers. To this, 200 ng of mRNA were added and the mixtures were heated to 65°C for 10 minutes. The reactions were then cooled to 25°C for 5 minutes and 1 µl superscript II Reverse Transcriptase (RT; Life Technologies) was added. Identical reaction mixtures were made for each mRNA sample without adding superscript II Reverse Transcriptase. These reactions served as no-RT controls. The reaction was heated to 37 °C for 90 minutes, followed by heat deactivation at 90°C for 10 min. The reaction was then diluted to 100 µl with H 2 O and stored at -20°C for later use.
Real-time PCR was performed using a GeneAmp 5700 Sequence Detection System (PE Applied Biosystems, Foster City, CA) and the SYBR Green PCR core reagents kit (PE Applied Biosystems). PCR parameters were 50°C for 2 min, 95°C for 10 min, 40 cycles of 95°C for 30 s, followed by 1.5 min at various annealing temperatures (IGF-I 
Hindlimb suspension and analysis of atrophy
In another experiment, mice were separated into three groups as described above. Mice were anesthetized with an intraperitoneal injection of ketamine/xylazine as described above, scanned using DEXA, and injected with IGF-I, Shh, or IGF-I + Shh. Three days after plasmid injection and electroporation, disuse atrophy was initiated in mice using hindlimb suspension. The hindlimb suspension model employed was a modification of that originally designed by Morey et. al (21) using custom hindlimb suspension cages built on modifications of plans described by Park and Schultz (22) . Seven days posthindlimb suspension, six mice from each animal group were anesthetized with an intraperitoneal injection of ketamine/xylazine as described and DEXA scanned. After the scan, mice were euthanized and gastrocnemius/soleus muscles were removed and weighed. Muscles were then embedded, cryosectioned, stained for ß-galactosidase activity, and analyzed as described above.
Statistical analysis
Comparisons between the LacZ-control and Lac-Z/growth factor injected muscles from each animal were made and compared using one-way analysis of variance followed by a Bonferroni Multiple Range Test using Graphpad Prism for Windows (Graphpad, San Diego, CA).
RESULTS
Weight-bearing mice
IGF-I and/or Shh were ectopically expressed in gastrocnemius/soleus muscles of 15-wkold mice. Compared with the contralateral control LacZ injected muscle fibers, muscles fibers ectopically expressing IGF-I were on average 46, 51, and 41% larger 7, 14, and 30 days post-DNA injection, respectively (Figs. 2 and 3; all differences, P<0.05). Muscles fibers ectopically expressing Shh were 41, 53, and 47% larger than contralateral control LacZ injected muscle fibers 7, 14, and 30 days post-DNA injection and electroporation, respectively (Figs. 2 and 3; all differences, P<0.05). Muscles fibers ectopically expressing IGF-I and Shh were 71, 76, and 62% larger than contralateral control LacZ injected muscle fibers 7, 14, and 30 days post-DNA injection and electroporation, respectively (Figs. 2 and 3; all differences, P<0.05).
To characterize the paracrine effects of ectopic expression of IGF-I and/or Shh on muscle growth, we examined the area of muscle fibers immediately adjacent to muscle fibers ectopically expressing DNA. Compared with the area of muscles fibers adjacent to contralateral control LacZ-expressing muscle fibers, the area of muscle fibers adjacent to fibers ectopically expressing IGF-I, Shh, or IGF-I+Shh were 28, 30, and 57% larger, respectively, 7 days post-DNA injection ( Figs. 2 and 4 ; all differences, P<0.05). To address the question of whether there was significant ectopic growth factor expression outside of the fibers that were expressing LacZ, it would have been suitable to perform immunohistochemistry for the ectopic protein expression on muscle sections. However, although we used muscles that showed no overt necrosis and mineralization in response to electroporation, there still seemed to be an insult to the muscle that appeared as a strong affinity for the secondary antibody during immunohistochemistry. Even on sections from muscles 30 days postelectroporation, there was a strong background of secondary antibody immunostaining that we could not block with MOM kits (Mouse On Mouse, Vector Laboratories) or excess quenching with unlabeled secondary antibodies. Therefore, to address the possibility that ectopic growth factor expression could be occurring in muscle fibers that were not LacZ positive, a green fluorescent protein (GFP) expression construct was coelectroporated with a LacZ expression construct into the skeletal muscle of mice at the following ratios: 1.5:1, 2:1, 5:1, and 10:1. We then sectioned the muscles and scored fibers that were LacZ and GFP positive. We found that for all of the different ratios there was an overall 96% correlation between LacZ and GFP positive fibers (data not shown). There was no significant variation from this number for any of the specific ratios of GFP and LacZ. The results from this experiment demonstrate that when two different DNAs are mixed and coelectroporated into skeletal muscle and that regardless of their ratio to one another, they transfect and express in the same population of fibers.
In addition to histological analysis, the hindlimbs of mice ectopically expressing IGF-I and/or Shh were scanned using DEXA. Seven days post-DNA injection, the muscle mass density of Shh, IGF-I, or IGF-I+Shh injected limbs was 7, 10, and 18% larger than those of the contralateral control limbs (Fig. 5, all differences, P<0.05 ). Ectopic expression of IGF-I or Shh+IGF-I in the gastrocnemius/soleus significantly increased BMD 5.3 and 5.0%, respectively, in weighted animals (Fig. 6A, all differences, P<0.05 ). Expression of Shh had no effect on BMD. Expression of Shh+IGF-I increased BMC 7.2% (Fig. 6B,  P<0.05) , whereas Shh or IGF-I alone had no effect.
RNA analysis
After ectopic expression of IGF-I, Shh, and IGF-I+Shh, expression of IGF-I was 244, 189, and 150% greater, respectively, when compared with ectopic expression of LacZ. After ectopic expression of Shh and IGF-I+Shh, expression of Shh was 381 and 444% increased, respectively, when compared with ectopic expression of LacZ. There was no change in expression of Shh after ectopic expression of IGF-I. Ectopic expression of IGF-I, Shh, and IGF-I+Shh resulted in significant increases in Gli-3, myogenin, Patched-1, and Patched-2 expression compared with ectopic expression of LacZ. Ectopic expression of Shh significantly decreased Gli-1, Ihh, and MyoD, whereas ectopic expression of IGF-I and IGF-I + Shh significantly increased the expression of these mRNAs. Ectopic IGF-I significantly increased smoothened expression. There was no detectable difference in the expression levels of GAPDH, indicating an equal amount of RNA was compared in the four treatments. These results are summarized in Table 1 .
Analysis of atrophy
IGF-I and/or Shh were ectopically expressed in gastrocnemius/soleus muscles of 15-wkold mice, and the mice were suspended by the tail for 7 days. Ten days post-DNA injection (7 days posthindlimb suspension), gastrocnemius/soleus muscles were collected and processed as described in Materials and Methods. As expected, hindlimb suspension caused a progressive loss of muscle mass density, muscle weight, and muscle fiber area of gastrocnemius/soleus muscles (compare LacZ injected suspended muscles versus LacZ injected weight-bearing control muscles in Figs. 7, 8, and 9) . Compared with the contralateral control LacZ injected muscles, ectopic expression of IGF-I and/or Shh significantly attenuated the lost muscle mass density associated with disuse atrophy (Fig.  7) . The loss of muscle mass density associated with 7 days of hindlimb suspension was inhibited an average 46, 41, and 51% in IGF-I, Shh, and IGF-I+Shh injected, suspended muscles, respectively, than those of contralateral control LacZ injected, suspended muscle ( Fig. 7 ; all differences, P<0.05). Compared with the contralateral control LacZ injected, suspended muscle, muscle weights of IGF-I , Shh, and IGF-I+Shh injected muscles were an average 13, 14, and 18% larger, respectively, 7 days posthindlimb suspension ( Fig. 8; all differences, P<0.05) . Finally, muscle fibers of IGF-I, Shh, and IGF-I+Shh injected suspended muscles were an average 36, 27, and 40% larger, respectively, than those of contralateral LacZ injected suspended muscle 7 days posthindlimb suspension ( Fig. 9 ; all differences, P<0.05). However, despite the of ability IGF-I and/or Shh to significantly reduce losses in muscle mass density, muscle weight and muscle fiber area associated with disuse atrophy, the growth factor injected muscles were still significantly smaller than muscles of weight bearing mice (Figures 7, 8, and 9 ).
Electroporation and ectopic expression of IGF-I and Shh attenuated the atrophy of skeletal muscle associated with hindlimb elevation. To determine the extent of ectopic expression that we were attaining to have this inhibitory effect on atrophy, we analyzed the area of muscle fibers within the gastrocnemius/soleus that were expressing ectopic DNA. We found that an average of 9.5% (range 7.3-12.9%; standard error 2.1%), 12.1% (range 6.8-21.5%; standard error 6.5%), and 11.8% (range 8.1-15.1%; standard error 2.7%) of the fibers were expressing ectopic DNA 7, 14, and 30 days postelectroporation, respectively. Therefore, it appears that ~10% of the fibers need to be transfected to have some attenuation effect on disuse-mediated atrophy.
Hindlimb suspension significantly decreased BMD and BMC (Fig. 10 , compare suspended means to weight-bearing control means). In comparison to the contralateral control limb expressing LacZ, ectopic expression of Shh, IGF-I, or Shh+IGF-I within the gastrocnemius/soleus significantly attenuated loss in BMC associated with hindlimb suspension (Fig. 10A, P<0.05) . Although there was a trend for inhibition, ectopic expression of Shh, IGF-I, or Shh+IGF-I had no significant effect on the loss of BMD associated with hindlimb suspension (Fig. 10B) .
DISCUSSION
The purpose of this study was to examine the potential anabolic mechanisms mediated by IGF-I and Shh within skeletal muscle and bone after electroporation into skeletal muscle in vivo. We found that electroporation and ectopic expression of IGF-I and/or Shh stimulated significant muscle fiber hypertrophy. In addition, electroporation of IGF-I and/or Shh attenuated parameters of muscle atrophy that normally occur during disuse. Presentation of ectopic IGF-I to skeletal muscle via injection or transgenic expression results in increased skeletal muscle mass (23, 24) . Our results demonstrate that a localized presentation of IGF-I after injection and electroporation caused an increase in muscle fiber size ranging from 40-50%. This increase corresponded with a 60% increase in average fiber diameter after injection and electroporation of constitutively active Akt, a downstream mediator of IGF-I hypertrophy (25) . In addition to stimulating fiber hypertrophy, electroporated IGF-I cDNA inhibited parameters associated with muscle atrophy. It appears that acute surges of ectopic IGF-I are a more efficient treatment for atrophy than chronic administration, as overexpression of IGF-I in skeletal muscle of transgenic mice did not prevent unloading-induced atrophy (26) . The inability of locally overexpressed IGF-I to attenuate unloading-induced skeletal muscle atrophy in a transgenic animal may be due to alterations in the IGF-I autocrine/paracrine pathways such as an increase in IGF receptor numbers, thereby mitigating a decrease in local IGF-I expression, a change in local IGF binding protein production, a change in postreceptor events, or the interactive effects of other hormones upregulated in response to increased IGF-I production (26) . Regardless, we demonstrated that localized muscle-specific expression of IGF-I via electroporation is an effective inhibitor of muscle atrophy when presented in an acute fashion. It is important to note that some injury can occur as a result of muscle electroporation. We have found the occurrence of this type of injury to be unpredictable in nature and the severity of injury to be highly variable. In our study, we only analyzed muscles that demonstrated minimal to no injury.
The role of Shh during postnatal skeletal muscle development has not been studied in detail. Shh appears to be responsible for myogenic induction in somites (27) , and retrovirally overexpressed Shh in the chick limb bud leads to muscle hypertrophy. Here, we report that ectopic expression of Shh significantly stimulated postnatal muscle hypertrophy and inhibited disuse atrophy. It is not yet clear as to how Shh stimulated fiber hypertrophy. Supplementation of Shh to primary cultures of embryonic myoblasts resulted in an increase in proliferation and myotube number (28) . Therefore, Shh could be stimulating satellite cell proliferation, differentiation, and fusion with the myofiber, thereby stimulating hypertrophy, or it could be regulating protein synthesis and degradation. Experiments are currently underway to determine the exact cellular mechanism by which Shh stimulates fiber hypertrophy.
IGF-I and Shh stimulated muscle fiber hypertrophy and attenuated disuse muscle atrophy to a similar extent. Although IGF-I and Shh have been found to have a synergistic relationship when stimulating somitic myogenesis (29) , there was no evidence of synergism between these two growth factors in our study. Ectopic IGF-I regulated expression of Shh intermediates and receptors, stimulating increases in Gli-1, Gli-3, smoothened, patched-1, and patched-2, all mediators of Shh activity. However, ectopic IGF-I significantly increased Shh mRNA levels. Therefore, it is impossible to distinguish if IGF-I is mediating these effects on Shh intermediates directly or indirectly. Regardless, we did not find an additive effect when combining IGF-I and Shh for inhibition of atrophy.
Electroporation and ectopic expression of Shh and IGF-I not only stimulated increases in muscle fiber area but also increased more regional parameters of skeletal muscle growth, including increases in muscle weight, muscle density, as well as bone mass BMC and BMD. Our data would not be the first to demonstrate that intramuscular synthesis of ectopic proteins can stimulate increases in systemic growth. Electroporation of GHRH into pig muscle stimulated a significant increase in body weight gain, a significant decrease in fat deposition, and a significant increase in BMD (30) . However, our data would be the first to demonstrate that growth factors produced by skeletal muscle after electroporation appeared to regulate the maintenance of adjacent bones during periods of disuse. Although IGF-I or Shh may have entered blood to regulate bone and muscle development in the contralateral limb, the fact that BMC was significantly greater in the growth factor treated limb than in the contralateral control limb demonstrated a significant localized effect of the muscle-derived growth factor. We hypothesize that two possible mechanisms could explain how electroporated IGF-I and Shh affected local bone mineral. First, ectopically synthesized growth factors acted directly on the bone. Second, the muscles producing ectopic growth factor did not atrophy to the extent that the contralateral control limb muscles did. Therefore, the inhibition of osteopenia could have been a more indirect inhibition due to the maintenance of muscle mass and persistence of the greater mechanical stimuli on the bones in the growth factor treated limb. Based on our results, it is impossible to distinguish which of these two mechanisms was the primary reason that bone was also affected after electroporation of muscle. We favor a hypothesis where the first mechanism played a significant role, based on evidence that infused and increased circulating levels of IGF-I and IGF-II led to increased BMD and BMC (13, 31) and the gastrocnemius and tibia are anatomically linked, proximal to one another and sharing a common blood supply (32) . In addition, increases in muscle mass can occur independent of increases in bone (33) . The mechanism by which loading of muscle and bone is sensed and translated into signals controlling organ development and maintenance remains a major question to be resolved in the field of musculoskeletal research. Our results suggest that growth factors synthesized by muscle can exert significant regulatory effects on adjacent bones. It will be important to determine the exact mechanism(s) by which muscle-derived IGF-I and Shh stimulate increases in bone mineral.
In summary, our results demonstrated that muscle DNA electroporation is a powerful, specific, and potentially useful tool for gene therapy for treatment of musculoskeletal disorders. We found that electroporation of ~10% of the muscle fibers of the gastrocnemius and soleus muscles can inhibit muscle and bone atrophy associated with reduced mechanical load. It will be important to identify what combinations of growth factors and signaling molecules can completely inhibit muscle atrophy and bone osteopenia associated with disuse. Gastrocnemius/soleus muscles were injected with IGF-I/LacZ, Shh/ LacZ, or Shh/IGF-I/LacZ expression constructs. Contralateral gastrocnemius/soleus muscles were injected with LacZ. Seven days post-DNA injection and electroporation, BMD (A) and BMC (B) were determined using DEXA analysis. *P < 0.05, vs. contralateral LacZ-injected muscle; ┬ indicates SE. Gastrocnemius/soleus muscles were injected and electroporated with expression constructs containing either IGF-I, Shh, IGF-I+Shh, or LacZ cDNAs. Mice were then hindlimb suspended to induce disuse atrophy. Seven days posthindlimb suspension, gastrocnemius/soleus muscles were isolated and weighed. Ectopic expression of IGF-I and/or Shh significantly attenuated muscle net weight loss associated with disuse atrophy. Control group is weight-bearing mice as described in Materials and Methods. *P < 0.05, weight-bearing control vs. hindlimb suspension. $P < 0.05, growth factor injected vs. contralateral LacZ-injected muscle; ┬ indicates SE. Gastrocnemius/soleus muscles were injected and electroporated with expression constructs containing either IGF-I, Shh, IGF-I+Shh, or LacZ cDNAs. Mice were then hindlimb suspended to induce disuse atrophy. Seven days posthindlimb suspension, muscle fiber area was analyzed using digital image analysis. Representative sections from anatomically similar regions of a gastrocnemius/soleus muscle from a mouse electroporated 10 days earlier with IGF-I and LacZ (A) or LacZ (B); Shh and LacZ (C) or LacZ (D); or Shh, IGF-I, and LacZ (E); or LacZ (F). G and H are LacZ positive myofibers from a weight-bearing control animal. Blue fibers are myofibers expressing ectopic DNA. Quantitative analysis of fiber areas is shown in I. Ectopic expression of IGF-I, Shh, and IGF-I/Shh significantly inhibited the decrease in muscle fiber area 7 days posthindlimb suspension. Bar = 50 µm. *P < 0.05, weight-bearing control vs. hindlimb suspension. $P < 0.05, growth factor injected vs. contralateral LacZ-injected muscle; ┬ indicates SE. . Weight bearing is a control group of nonsuspended mice as described in Materials and Methods. *P < 0.05, weight-bearing control vs. hindlimb suspension. $P < 0.05, growth factor injected vs. contralateral LacZ-injected muscle; ┬ indicates SE.
